Small Hospitals
Market Cap
₹2,551 ₹2,551 Cr.
P/E
33.47
PEG
1.82
PEG = P/E ÷ 5yr forward EPS CAGR
5yr forward EPS CAGR thesis · Base case

The thesis comes alive if the company delivers the planned network expansion while improving productivity at each location.

The bull path requires faster location additions and stronger revenue generation per location, with better fixed-cost absorption.

The bear path reflects slower expansion combined with weaker location productivity, compounded by execution, doctor-availability and startup-cost pressures.

Key Ratios

Debt to Equity
Debt to Equity
0.24
Div Yield (%)
Div Yield (%)
0.13
Individual < 2 lac
Individual < 2 lac
13.27 %
Institutions
Institutions
4.29 %
Market cap
Market cap
2,551 Cr
No. of Shareholders
No. of Shareholders
22,954
OPM (%)
OPM (%)
30.48 %
PE
PE
33.47
Prom Holding
Prom Holding
72.67 %
ROCE (%)
ROCE (%)
14.44
ROE (%)
ROE (%)
20.24
Sales
Sales
496 Cr
  • Dr Agarwals Eye Hosp
  • Apollo Hospital Ent.
  • Max Healthcare Inst.
  • TJI Hospitals
Last updated on 27 Aug 2026
  • Dr Agarwal's runs India-only eye-care hospitals; consultation, surgery, diagnostics plus optical, pharma and contact-lens sales.
  • Earnings from single-segment eye-care; incremental profit tied to new greenfields and deeper Tamil Nadu reach.
  • New Chennai flagship under construction; ₹197.32Cr work-in-progress awaiting conversion to operating sites.
  • Cash-intensive build; operating cash funds capex but leases dominate balance sheet; closing cash thin.
  • Near term turns on parent AHCL merger sanction and effectiveness.
  • Material dependence on parent AHCL for funding and balances; audit-trail gaps persist in legacy and new systems.
  • FY26 final dividend and remuneration 9 Sep 2026
    settles ₹4/share dividend and Amar Agarwal and Athiya Agarwal pay revisions.
  • Scheme completion and effectiveness No timeline
    decides 23:2 share exchange, 1 Apr 2026 appointed date, liability transfer and dilution.
  • New Chennai Main Hospital build-out No COD stated
    converts ₹197.32Cr work-in-progress into operating capacity; cost overruns and impairment resolved.
  • Preferential-issue proceeds use No timeline
    resolves balance after ₹22.16Cr utilised versus temporary debt-fund parking.
  • Audit-trail remediation No timeline
    settles whether Neo logging, legacy Ideamed records and NetSuite controls close gaps.
Price Range

See where the stock is trading versus its 52-week high and low.

Low
4412
52W Range
High
6392
Timeline

Key company specific updates.

Custom financial statement

Edit rows

Forensics

11 Yes

Positive for this company

2 Neutral

Neutral for this company

4 No

Negative for this company

0 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Therapeutic Area Wise Break-Up - Domestic

Location Wise Break-Up

Peer Comparison

Corporate Actions

Consolidated
DATE
DETAILS
Show More
Show Less
Show More
Show Less

FAQs on Dr Agarwals Eye Hospital Ltd. Business

Dr Agarwals Eye Hospital Ltd is a leading medical facility in the field of Ophthalmic care, known for its pioneering medical advancements, highly skilled specialists, and a wide range of services including surgeries and customized eye treatments.

Dr Agarwals Eye Hosp major competitors are Apollo Hospital Ent., Max Healthcare Inst., Fortis Healthcare, Global Health, Narayana Hrudayalay., Krishna Inst.Medi, Aster DM Quality.
Market Cap of Dr Agarwals Eye Hosp is ₹2,566 Crs.
While the median market cap of its peers are ₹64,704 Crs.

Dr Agarwals Eye Hosp seems to be less financially stable compared to its competitors.
Altman Z score of Dr Agarwals Eye Hosp is 4.6 and is ranked 8 out of its 8 competitors.

Company Filing

2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Annual Report FY26 FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
Earnings Release
Investor Presentation Aug
Conference Call
Conference Call SummaryCon Call Summary

Discussions & Analysis

Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material